Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 09, 2021
Fareva and ApiJect Systems, Corp. have announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large ...
read more
FAMAR Group has signed a contract manufacturing agreement with GE HealthCare to fill and finish vials of GE HealthCare's iodine-based contrast media, at its newly acquired site in Homburg, Germany, with commercial supply due to begin in 2028.
read more
Famar has announced the planned acquisition of the Pointe-Claire, Quebec, a manufacturing site from the Consumer Health Division of Bayer.
read more
Wednesday, February 10, 2021
FairJourney Biologics and IONTAS have announced the launch of a new protein sciences division, Flow Eighteen38.
read more
Tuesday, December 01, 2020
FairJourney Biologics and IONTAS have signed an agreement to discover antibodies with Pandion Therapeutics.
read more
Patient-focused pharmaceutical company continues to partner with hospitals and ambulatory surgery centers to meet increased demand for essential compounded sterile medication during, and beyond, COVID-19; 503B outsourcing supports patient safety and ...
read more
Thursday, February 03, 2022
Fagron has reached an agreement to acquire Letco Medical. The acquisition price is $34 million.
read more
Wednesday, March 25, 2020
Factory-CRO Group announced its rebranding as Avania.
read more
Factory-CRO Group has announced Sapna Hornyak as its new president and CEO and the appointment of Nick Thornton to chairman of its board of directors.
read more
Thursday, October 26, 2017
Factory CRO announced the acquisition of MileStone Research Organization.
read more
F-star announced a new partnership with Merck for the development and commercialization of five bispecific immuno-oncology antibodies (mAb2).
read more
Wednesday, January 29, 2020
EyePoint and Ocumension announced a license agreement for development and commercialization of DEXYCU 9% for post-operative inflammation following ocular surgery in Mainland China, Hong Kong, Macau and Taiwan.
read more
EyePoint has entered into a purchase and marketing agreement with Vantage Outsourcing for Dexycu.
read more
Monday, November 04, 2019
EyePoint Pharmaceuticals has entered into a formal three-year contract with Vizient effective November 1, 2019, to offer DEXYCU®.
read more
Friday, December 06, 2019
EyePoint Pharmaceuticals announced the Company has entered into a formal two-year contract with one of the largest integrated delivery systems in the U.S. to offer DEXYCU within its network.
read more